Bristol Myers Squibb

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!
Yesterday
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6%… PR Newswire (Press Release)17:38 17-Feb-26
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for… Business Wire (Press Release)07:06 17-Feb-26
What Bristol-Myers Squibb (BMY)'s Earnings Rebound and Completed Buybacks Mean For Shareholders Simply Wall St04:59 17-Feb-26
In the last 7 days
Bristol-Myers Squibb Expands Real-World MDS Footprint in Asia With New Registry Study TipRanks11:41 13-Feb-26
Bristol-Myers Squibb Earnings Strength And Pipeline Shape Future Valuation Simply Wall St11:33 13-Feb-26
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period… PR Newswire (Press Release)17:33 11-Feb-26
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:04 11-Feb-26
Zydus Life cleared to sell life-saving cancer drug; SC tells Bristol Myers to map patents The Economic Times02:42 11-Feb-26
In the last month
BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? Zacks11:32 9-Feb-26
BMS partners with Evinova to strengthen clinical development using AI European Pharmaceutical Review07:53 9-Feb-26
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development … Business Wire (Press Release)01:06 9-Feb-26
StockWatch: Better than Expected Q4 Lifts BMS Shares Genetic Engineering and Biotechnology News19:28 8-Feb-26
BMS reports flat revenue growth for full-year 2025 Pharmaceutical Technology06:18 6-Feb-26
Why Bristol Myers Squibb Stock Topped the Market Today The Motley Fool17:22 5-Feb-26
Bristol Myers Flags Data-Rich 2026 After Solid Quarter Benzinga10:10 5-Feb-26
Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue Estimates Zacks09:12 5-Feb-26
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025 Barchart08:39 5-Feb-26
Bristol Myers Squibb Posts 2025 Results, Raises Dividend TipRanks07:38 5-Feb-26
Bristol-Myers Squibb Guides FY26 Above Estimates - Update RTT News07:33 5-Feb-26
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025 Business Wire (Press Release)07:02 5-Feb-26
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer Pharmafile04:45 5-Feb-26
Notable Wednesday Option Activity: MCK, RKLB, BMY Nasdaq15:50 4-Feb-26
What's Going On With Bristol-Myers Squibb Stock Today? Benzinga13:47 4-Feb-26
Earnings Preview: Bristol-Myers Squibb Benzinga10:23 4-Feb-26
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi Business Wire (Press Release)07:03 4-Feb-26
Oxford BioMedica expands cancer therapy deal with Bristol-Myers Squibb London South East07:01 4-Feb-26
Oxford Biomedica signs expanded car‑T supply pact with Bristol Myers Squibb ShareCast03:23 4-Feb-26
Bristol-Myers Squibb Earnings: What To Look For From BMY Barchart22:22 3-Feb-26
Unveiling Bristol Myers (BMY) Q4 Outlook: Wall Street Estimates for Key Metrics Zacks10:19 2-Feb-26
STAT Plus: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s STAT04:32 2-Feb-26
See Which Of The Latest 13F Filers Holds BMY Nasdaq10:15 30-Jan-26
Will BMY's Oncology Collaborations Drive Its Next Growth Phase? Zacks09:58 30-Jan-26
A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Momentum Simply Wall St09:09 30-Jan-26
Bristol Myers moves SC to stop Zydus from selling biosimilar cancer drug The Economic Times15:35 29-Jan-26
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for Zacks11:04 29-Jan-26
Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note Zacks18:55 28-Jan-26
Piramal Pharma to Acquire Kenalog Injectable Portfolio from Bristol-Myers Squibb TipRanks16:10 28-Jan-26
The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears Pharmaceutical Technology10:04 28-Jan-26
Bristol-Myers Squibb Stock Outlook: Is Wall Street Bullish or Bearish? Barchart05:31 28-Jan-26
Bristol-Myers Squibb Advances Repotrectinib Interaction Study: What Investors Should Know TipRanks11:34 26-Jan-26
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know Zacks10:10 26-Jan-26
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term. The Motley Fool18:58 23-Jan-26
Bristol Myers Squibb Co. v. HHS, Janssen Pharmaceuticals Inc. v. HHS U.S. Chamber of Commerce (Press Release)15:53 23-Jan-26
Bristol-Myers Squibb and BioNTech Advance New Phase 3 Lung Cancer Trial With Pumitamig TipRanks11:38 23-Jan-26
Bristol-Myers Squibb and BioNTech Advance New Lung Cancer Weapon Against Keytruda in Phase 3… TipRanks11:38 23-Jan-26
JANX Enters Global Oncology Collaboration With BMY, Stock Rises Zacks08:27 23-Jan-26
BMS bets on Janux’s novel solid tumour therapy through $850m deal Pharmaceutical Technology04:08 23-Jan-26
Janux’s tumor-activated platform draws BMS in potential $850M deal BioWorld17:16 22-Jan-26
Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million Benzinga14:06 22-Jan-26
Janux Enters Collaboration And Exclusive Worldwide License Agreement With Bristol Myers Squibb RTT News08:19 22-Jan-26
Janux Therapeutics stock soars after Bristol Myers Squibb collaboration Investing.com07:45 22-Jan-26
Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with… Business Wire (Press Release)07:04 22-Jan-26
[JPM 2026] Big pharma eyes ‘post-ADC’ solutions as Orum’s DAC draws interest Korea Biomedical Review21:26 21-Jan-26
Syngene International verlängert langfristige Forschungszusammenarbeit mit Bristol Myers Squibb … PR Newswire (Press Release)11:16 21-Jan-26
BMS and Microsoft partner for AI-based lung cancer detection Pharmaceutical Technology06:00 21-Jan-26
Syngene International extiende su colaboración de investigación con Bristol Myers Squibb PR Newswire (Press Release)05:09 21-Jan-26
Microsoft forges AI cancer detection pact Mobile World Live04:29 21-Jan-26
BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? Zacks14:50 20-Jan-26
Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool Benzinga13:11 20-Jan-26
Microsoft and Bristol Myers Squibb team up to deploy AI for early lung cancer detection Crypto Briefing08:53 20-Jan-26
Bristol Myers partners with Microsoft for AI-driven lung cancer detection Yahoo! UK & Ireland08:18 20-Jan-26
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early… Business Wire (Press Release)07:09 20-Jan-26
NICE recommends Bristol Myers Squibb’s nivolumab Pharmaceutical Field05:48 20-Jan-26
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035 Manufacturing Chemist04:19 20-Jan-26
2 Dividend Stocks to Buy and Hold For 10 Years The Motley Fool14:45 19-Jan-26
Syngene expands research collaboration with Bristol Myers Squibb The Times of India10:19 19-Jan-26
Syngene - Bristol Myers Squibb collaboration extended to 2035 The Hindu Business Line03:19 19-Jan-26
Syngene Extends and Expands Bristol Myers Squibb Research Alliance to 2035 TipRanks00:56 19-Jan-26

      
            
      
    view more headlines
   
      
      
      
17 Feb 17:38
   
Bristol Myers Squibb News

NewsNow brings you the latest news from the world’s most trusted sources on Bristol Myers Squibb. NewsNow aims to be the world’s most accurate and comprehensive Bristol Myers Squibb news aggregator, bringing you the latest headlines automatically and continuously 24/7.
Bristol Myers Squibb

Bristol Myers Squibb News

Pharmaceuticals Top Stories

Business Top Stories
